MRSH · MARSH & MCLENNAN COMPANIES, INC.

456 filings

MRSH SEC Filings

MARSH & MCLENNAN COMPANIES, INC. - 456 total filings

Filing record · 2016–202610-K1110-Q338-K115

Showing 1–50 of 456 filings

MARSH & MCLENNAN COMPANIES, INC. Quarterly Report for Q3 Ended Sep 30, 2026

Marsh & McLennan Companies, Inc. (MRSH) reported solid revenue growth in the third quarter and first nine months of fiscal year 2026, driven by its Risk & Insurance Services and Consulting segments. Consolidated revenue increased by 8% and 7% respectively for these periods on a reported basis, with underlying growth of 5% in both periods. While operating income saw a modest increase of 4% for the quarter, it experienced a 3% decrease year-to-date. Net income attributable to the company and diluted EPS showed strong year-over-year growth for the quarter, but a slight decrease for the nine-month period. The company's financial performance reflects continued demand for its services, strategic acquisitions, and effective cost management, though it also navigated a significant settlement related to the Greensill litigation. The company's balance sheet remains robust with total assets of $59.8 billion. While liabilities have increased, primarily due to debt, equity also saw an increase. Cash flow from operations was strong, although lower than the previous year's comparable period. The company continued to return capital to shareholders through share repurchases and dividends, demonstrating a commitment to shareholder value.

Oct 15, 2026 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Financial Results (Oct 15, 2026)

Marsh & McLennan (NYSE: MRSH) reported third quarter 2026 results on October 15, 2026, furnished under Item 2.02 via Exhibit 99.1. Consolidated revenue rose 8% to $6.9 billion (5% underlying), and GAAP diluted EPS was $1.69, up from $1.51. Adjusted EPS rose 10% to $2.03. GAAP operating income grew 4% to $1.2 billion, while adjusted operating income grew 6% to $1.5 billion. The quarter's growth was led by Management Consulting (up 14%) and Risk (up 5% underlying), with Reinsurance down 6%. Growth in Risk was concentrated in EMEA, which rose 7% underlying. For the nine months, GAAP operating income fell 3% to $4.9 billion, reflecting roughly $743 million of Risk-segment noteworthy items, including a $569 million Greensill litigation charge. Adjusted operating income rose 7% to $6.1 billion and adjusted EPS rose 9% to $8.29. GAAP nine-month diluted EPS was $6.68, down from $6.75. Nine-month underlying revenue growth was 5%, with Consulting up 7%, Risk and Insurance Services up 3%, and People and Investments up 5%. Capital deployment was active. The company repurchased 2.7 million shares for $500 million in the quarter and $2.0 billion year to date, and it repaid a €550 million senior note. Year-end debt rose, with short-term debt at $1.6 billion and long-term debt at $18.9 billion. Cash from operations fell to $2.3 billion for the nine months from $3.1 billion a year earlier, driven mainly by a $872 million increase in net receivables. The company also disclosed Thrive program restructuring costs, a brand transition to "Marsh," and segment renaming.

Oct 15, 2026 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Financial Results (Jul 21, 2026)

Marsh & McLennan (NYSE: MRSH) reported second-quarter 2026 results with consolidated revenue of $7.4 billion, up 6% on a GAAP basis and 5% on an underlying basis. GAAP operating income rose 4% to $1.9 billion, and adjusted operating income rose 5% to $2.2 billion. Diluted GAAP EPS was $2.63, up from $2.45, and adjusted EPS grew 9% to $2.96. Growth was led by Consulting, where revenue rose 10% (8% underlying) and Marsh Management Consulting grew 15%. Risk & Insurance Services revenue rose 4% (3% underlying), with Marsh Risk up 4% underlying and Guy Carpenter down 2%. The six-month picture is weaker on a GAAP basis. Six-month GAAP operating income fell 5% to $3.7 billion and diluted GAAP EPS fell to $4.99 from $5.23. The main driver is a $425 million charge for Greensill litigation in Risk & Insurance Services, which the company excludes from adjusted results. On an adjusted basis, six-month operating income rose 7% to $4.6 billion and adjusted EPS rose 8% to $6.25. Investors should weigh the GAAP and adjusted figures together, since the gap between them is large this period. Capital returns remained active. The company repurchased about 4.5 million shares for $750 million in the quarter, bringing year-to-date repurchases to $1.5 billion. The Board raised the quarterly dividend 10% to $0.990 per share, payable August 14, 2026. Note that the earnings release is furnished under Item 2.02 and is not deemed filed for Section 18 purposes.

Jul 21, 2026 10-Q

MARSH & MCLENNAN COMPANIES, INC. Quarterly Report for Q2 Ended Jun 30, 2026

Marsh & McLennan Companies, Inc. (MMC) reported solid revenue growth in the second quarter and first half of 2026, with consolidated revenue increasing by 6% and 7% respectively, driven by strong performance in both its Risk & Insurance Services and Consulting segments. Diluted EPS saw a healthy increase of 7% year-over-year for the quarter, though it decreased by 5% for the year-to-date period, largely impacted by a significant $425 million charge related to the Greensill litigation. The company continues to execute on its strategic initiatives, including ongoing acquisitions and the "Thrive" efficiency program. Management remains focused on delivering value to clients and improving operational efficiency, while navigating macroeconomic uncertainties and regulatory landscapes.

Jul 21, 2026 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Material Agreement (Jun 4, 2026)

Marsh & McLennan Companies, Inc. (MRSH) has announced the establishment of a new, larger revolving credit facility. On June 2, 2026, the company entered into an Amended and Restated 5 Year Credit Agreement, replacing its previous facility. This new facility increases the aggregate borrowing capacity to $4.25 billion, up from $3.5 billion, and extends the term to June 2031. The facility is unsecured and multi-currency, with interest rates tied to Term SOFR plus a margin that varies with the company's credit ratings. This refinancing demonstrates the company's proactive approach to managing its liquidity and capital structure. The increased credit line provides enhanced financial flexibility for potential future investments, acquisitions, or other strategic initiatives. Investors should note that the facility requires the company to maintain specific coverage and leverage ratios, which will be tested quarterly, indicating a continued focus on financial discipline and creditworthiness.

Jun 4, 2026 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Shareholder Vote Results (May 22, 2026)

Marsh & McLennan Companies, Inc. (MRSH) filed an 8-K report on May 22, 2026, detailing the results of its Annual Meeting of Stockholders held on May 21, 2026. The meeting saw a high turnout, with over 90% of outstanding common stock represented. Key outcomes include the election of all thirteen director nominees for a one-year term, overwhelming approval of executive compensation through a non-binding vote, and the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for 2026. These results indicate strong shareholder confidence in the company's leadership and governance structure. The voting outcomes demonstrate robust support for the incumbent board of directors, with each nominee receiving a substantial majority of votes in favor. The advisory vote on executive compensation also passed with significant approval, reflecting shareholder alignment with the company's compensation philosophy. Furthermore, the ratification of the auditor reinforces the company's commitment to transparency and sound financial reporting practices. Overall, the filing suggests a stable and supportive shareholder base for Marsh & McLennan Companies.

May 22, 2026 10-Q

MARSH & MCLENNAN COMPANIES, INC. Quarterly Report for Q1 Ended Mar 31, 2026

Marsh & McLennan Companies, Inc. (MRSH) reported solid revenue growth for the first quarter of 2026, with consolidated revenue increasing by 8% to $7.6 billion. This growth was driven by increases in both the Risk and Insurance Services (6% revenue growth) and Consulting (11% revenue growth) segments. However, operating income saw a significant decrease of 12% to $1.8 billion, primarily due to a $425 million charge related to the Greensill litigation. Diluted Earnings Per Share (EPS) declined by 15% to $2.36. The company continued its strategic acquisitions, completing two in the first quarter. Shareholder returns were supported by $750 million in share repurchases and a declared quarterly dividend of $0.900 per share. While revenue performance was strong, the substantial charge for litigation and increased operating expenses impacted profitability. Investors should monitor the resolution of the Greensill litigation and its potential impact on future earnings.

Apr 16, 2026 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Financial Results (Apr 16, 2026)

Marsh & McLennan Companies (NYSE: MRSH) reported first-quarter 2026 results that combined solid top-line and underlying performance with a large GAAP earnings decline. Revenue rose 8% to $7.6 billion, or 4% on an underlying basis after a roughly 3-point currency tailwind. Adjusted operating income grew 8% to $2.41 billion, and adjusted EPS rose 8% to $3.29. Consulting was the standout, with revenue up 11% (5% underlying) and adjusted operating income up 13%, led by Mercer and Marsh Management Consulting. Risk and Insurance Services grew more modestly, with underlying revenue up 3%. GAAP results were materially weaker. Operating income fell 12% to $1.75 billion and GAAP diluted EPS fell to $2.36 from $2.79, mainly because of a $425 million charge tied to Greensill litigation. Excluding that charge and other noteworthy items, the quarter looks healthy. Investors will need to judge whether the litigation charge is a one-time item or a sign of continuing legal exposure. Underlying growth of 4% is also modest for a company of this scale, and Marsh Risk's U.S./Canada underlying growth of 3% and Guy Carpenter's 2% suggest the insurance broking and reinsurance businesses are growing more slowly than consulting. Capital allocation remained active. The company repurchased about 4.2 million shares for $750 million, and shares outstanding fell to 482 million from 493 million a year earlier. Net debt-related activity was roughly neutral, with $600 million of senior notes issued and $600 million repaid. A $436 million dividend payable appeared on the balance sheet at quarter-end. Operating cash flow was negative, as is typical for Q1 given annual incentive payouts, with accrued compensation falling from $3.96 billion to $1.95 billion. Total equity declined to $14.8 billion from $15.3 billion, partly reflecting buybacks and dividends.

Apr 16, 2026 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Executive Changes (Apr 14, 2026)

Marsh & McLennan Companies (NYSE: MRSH) filed an 8-K on April 14, 2026 announcing that Chief Financial Officer Mark McGivney will take on the additional role of Executive Vice President and Chief Operating Officer, effective April 15, 2026. He will continue as CFO, making him the combined COO and CFO. According to the press release, he will support CEO John Doyle and the Marsh Executive Committee in evolving and accelerating strategy, particularly for initiatives spanning multiple businesses, and will lead the company's inorganic (M&A) strategies and ensure execution of top priorities. The Executive Committee will continue to report to Doyle. The filing discloses the compensation package tied to the expanded role: a base salary of $1,250,000; an annual bonus target of $3,450,000 beginning with the 2026 performance year (paid February 2027); a long-term incentive target of $6,300,000 beginning with the 2027 award; and a one-time $10 million stock unit grant on May 1, 2026 vesting in three equal annual installments starting May 15, 2027. The Compensation Committee approved these terms on April 8, 2026. For investors, the key takeaways are that the company is consolidating operational and financial leadership under a long-tenured executive (nearly 20 years at the firm, CFO since January 2016) and placing M&A responsibility with him, which signals a continued emphasis on acquisitions and cross-business initiatives. The filing does not disclose financial results, guidance, or a reason for any CFO succession, and no successor CFO is named, so investors may want to monitor whether a separate finance leader is appointed and how the combined role affects execution and governance.

Apr 14, 2026 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Executive Changes (Mar 10, 2026)

Marsh & McLennan Companies, Inc. (NYSE: MRSH) disclosed in a Form 8-K filed March 10, 2026 that it is making a senior leadership change in its Marsh Risk business. Nick Studer, currently CEO of Oliver Wyman and Marsh Management Consulting, will succeed Martin South as President and CEO of Marsh Risk, effective April 1, 2026. Martin South, in turn, becomes Senior Vice President and Chief Client Officer of the Company, an enterprise-wide client-focused role. Both executives remain on the Executive Committee and report to CEO John Doyle. The company also said it expects to name a new CEO of Oliver Wyman and Marsh Management Consulting by April 1. The filing is primarily a management reshuffle rather than a financial event; it contains no reported financial results, guidance changes, or material charges. Management frames the moves as tools to accelerate growth, increase agility, and deepen client value, with an explicit emphasis on applying AI and data analytics to the client experience. Investors will likely watch whether the changes translate into revenue growth and margin performance in Marsh Risk and in the consulting segment, and whether the pending Oliver Wyman successor is a meaningful strategic choice. From a governance and compensation standpoint, the Compensation Committee approved an amendment to South's terms on March 5, 2026. He keeps his current base salary, receives a 2026 annual bonus target of $1,500,000 and a 2027 long-term incentive target of $1,750,000, and gains 12 months of severance protection from April 1, 2026 under the Senior Executive Severance Pay Plan, applied as if he were terminated without Cause. Those terms are modest relative to a company of this scale and are the most concrete financial disclosure in the filing.

Mar 10, 2026 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Executive Changes (Feb 25, 2026)

Marsh & McLennan Companies, Inc. (NYSE: MRSH) disclosed in a Form 8-K filed February 25, 2026 that its Board of Directors appointed Peter Harrison as an independent non-management director, effective immediately. The appointment expands the Board to 13 directors. This is a governance event rather than a financial one: the filing contains no financial results, guidance, or changes to operations, capital allocation, or leadership of executive management. Mr. Harrison brings over three decades of investment management and executive leadership experience. He retired from Schroders plc in 2024, where he served as CEO from 2016 and previously as Global Head of Investment. He also led RWC Partners (now RedWheel) as Chairman and CEO from 2006 to 2013 and served as Global Chief Investment Officer of Deutsche Bank's asset management businesses from 2004 to 2006. He currently serves on the boards of Lazard, Inc. and Morgan Sindall plc, where he is Chair. The company's press release frames the appointment as strengthening the Board's investment and financial services expertise, aligned with Marsh's growth and innovation agenda. For investors, the key items to monitor are Mr. Harrison's committee assignments, which the company has not yet determined and expects to disclose in its 2026 definitive proxy statement, and his director compensation, which will follow the company's standard independent director arrangements described in a previously filed 10-Q exhibit. Because his appointment is effective immediately and no committee roles have been assigned, the near-term impact on governance and oversight is likely modest.

Feb 25, 2026 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Corporate Update (Feb 19, 2026)

Marsh & McLennan Companies, Inc. (MRSH) has filed an 8-K report detailing the issuance of $600 million in aggregate principal amount of 4.950% Senior Notes due 2036. This issuance, finalized through an underwriting agreement with Citigroup Global Markets Inc., J.P. Morgan Securities LLC, and Wells Fargo Securities, LLC, was conducted under the company's existing shelf registration statement. The notes were issued on February 19, 2026, and are governed by a supplemental indenture dated the same day. This action represents a routine financing activity for the company, allowing it to raise capital through the debt markets. Investors should note the specific coupon rate and maturity date of these new senior notes as part of their assessment of the company's debt structure and financial leverage.

Feb 19, 2026 10-K

MARSH & MCLENNAN COMPANIES, INC. Annual Report, Year Ended Dec 31, 2025

Marsh & McLennan Companies, Inc. (MRSH) reported strong financial performance for the fiscal year ending December 31, 2025. The company generated $27.0 billion in consolidated revenue, representing a 10% increase (4% on an underlying basis) compared to the prior year. This growth was driven by robust performance in both the Risk and Insurance Services segment, which saw revenue increase by 12% to $17.3 billion, and the Consulting segment, with revenue up 7% to $9.8 billion. Net income attributable to the company rose to $4.2 billion, resulting in diluted earnings per share of $8.43, a 3% increase year-over-year. The company continues to execute its strategic growth initiatives, including significant investment in technology and operational efficiency through its 'Thrive' program. Acquisitions remain a key part of the strategy, with the company completing 20 acquisitions in 2025 for a total consideration of $857 million. Notably, the McGriff acquisition, completed in late 2024, significantly contributed to the Risk and Insurance Services segment's growth. Marsh & McLennan also demonstrated a strong commitment to shareholder returns, repurchasing $2.0 billion of its common stock and paying $1.7 billion in dividends during 2025. The company's financial position remains solid, with a credit rating of A- (Stable) from S&P and Fitch, and A3 (Stable) from Moody's.

Feb 9, 2026 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Financial Results (Jan 29, 2026)

Marsh (NYSE: MRSH, formerly MMC) reported fourth-quarter and full-year 2025 results on January 29, 2026, furnished under Item 2.02 as Exhibit 99.1. Full-year 2025 GAAP revenue rose 10% to $27.0 billion, but underlying growth was a more modest 4%, with the gap driven largely by the McGriff acquisition. GAAP operating income grew 7% to $6.2 billion, while adjusted operating income rose 11% to $7.3 billion. GAAP diluted EPS was $8.43 versus $8.18 in 2024, and adjusted EPS grew 9% to $9.75. Fourth-quarter GAAP EPS was $1.68 and adjusted EPS rose 10% to $2.12, though the adjusted figure included a 7-cent benefit from discrete tax items and a 2-cent FX benefit. The quality of growth is the key investor question. Acquisition contribution (McGriff) inflated headline revenue, while organic growth was roughly 4% for the year and only 2% in Risk & Insurance Services in Q4. Marsh Risk's U.S./Canada underlying growth was 3% in Q4, and Latin America declined 4%. Consulting was the stronger organic performer at 5% underlying growth for both Q4 and the full year, led by Mercer Wealth. Management cites 18 consecutive years of reported margin expansion, but adjusted margin was 27.1% for 2025 versus 26.8% in 2024, and GAAP operating margin of 23.1% was roughly flat versus 23.8% in 2024, a decline. Interest expense rose sharply to $960 million from $700 million, reflecting acquisition financing, which weighs on GAAP net income. Capital allocation and corporate changes were also notable. The company repurchased 10.1 million shares for $2.0 billion in 2025 and paid $1.7 billion in dividends, while total debt increased to roughly $19.6 billion (short-term plus long-term) from about $20.0 billion, with short-term debt rising to $1.27 billion. Management rebranded its segments (Marsh Risk, Marsh Management Consulting), launched the three-year Thrive efficiency program, and changed its NYSE ticker to MRSH on January 14, 2026. Thrive-related restructuring charges (about $222 million in 2025) are excluded from adjusted results, so investors should monitor whether promised savings materialize.

Jan 29, 2026 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Bylaw Amendment (Jan 14, 2026)

Marsh & McLennan Companies, Inc. (MRSH) has filed an 8-K report on January 13, 2026, announcing significant updates to its corporate governance through amended and restated bylaws, effective January 14, 2026. These changes are primarily aimed at aligning the company's operational procedures with recent amendments to the Delaware General Corporation Law (DGCL) and modern proxy regulations. Key adjustments include modifications to advance notice provisions for director nominations and shareholder proposals, incorporating requirements for enhanced stockholder disclosures and reflecting universal proxy rules. The amendments also clarify voting standards for stockholder matters and the authority of the meeting chair, alongside general updates for procedural and informational requirements. Investors should note that these changes enhance transparency and procedural fairness in shareholder engagement and governance processes.

Jan 14, 2026 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Financial Results (Oct 16, 2025)

Marsh & McLennan (NYSE: MMC, to be renamed MRSH in January 2026) reported third quarter 2025 results on October 16, 2025, with consolidated revenue of $6.4 billion, up 11% on a GAAP basis but only 4% on an underlying basis, which strips out currency and acquisition effects (principally the McGriff acquisition). Operating income rose 6% to $1.17 billion, while adjusted operating income rose 13% to $1.44 billion. GAAP diluted EPS was $1.51, flat year over year, and adjusted EPS grew 11% to $1.85. The gap between GAAP and adjusted results is largely driven by identified intangible amortization ($133 million in the quarter, up from $90 million) and McGriff integration costs, so investors should weigh the adjusted figures carefully. The quarter's underlying growth was modest but steady. Marsh's underlying revenue rose 4% (U.S./Canada 3%, international 5%), Guy Carpenter grew 5%, Mercer grew 3%, and Oliver Wyman grew 8%. Interest expense jumped to $237 million from $154 million, reflecting higher debt following the McGriff financing, which weighed on pre-tax income that was essentially flat at $1.01 billion. Management also launched a three-year Thrive efficiency program (restructuring costs of $46 million in the quarter) and created a Business and Client Services unit. Balance sheet and capital return items were active. Dividends payable of $441 million were recorded at quarter-end, the company repurchased $400 million of stock in the quarter ($1.0 billion year to date), and total debt rose to about $19.6 billion including short-term borrowings of $1.26 billion. Nine-month operating cash flow of $3.1 billion was up sharply from $2.3 billion. The company also announced a rebranding to Marsh, with its four businesses adopting the Marsh name beginning in 2027 and a ticker change to MRSH in January 2026.

Oct 16, 2025 10-Q

MARSH & MCLENNAN COMPANIES, INC. Quarterly Report for Q3 Ended Sep 30, 2025

Marsh & McLennan Companies, Inc. (MRSH) reported solid financial results for the nine months ended September 30, 2025, demonstrating resilience and growth. Consolidated revenue increased by 11% to $20.4 billion compared to the prior year, driven by robust performance in both the Risk and Insurance Services (RIS) and Consulting segments. Operating income saw a notable 7% increase to $5.0 billion, reflecting effective operational management amidst rising expenses. Diluted earnings per share (EPS) grew to $6.75, up from $6.59 in the prior year, indicating enhanced profitability. The company also continues to invest in growth through strategic acquisitions, with eight acquisitions in RIS and four in Consulting during the first nine months of the year. Additionally, Marsh McLennan launched its "Thrive" restructuring program, aimed at driving efficiency and growth, while also returning capital to shareholders through share repurchases and dividends.

Oct 16, 2025 10-Q

MARSH & MCLENNAN COMPANIES, INC. Quarterly Report for Q2 Ended Jun 30, 2025

Marsh & McLennan Companies, Inc. (MRSH) reported a strong financial performance for the second quarter and first half of 2025. Total revenue saw a significant increase of 12% year-over-year for the quarter, reaching $7.0 billion, and a 11% increase to $14.0 billion for the six-month period. This growth was driven by robust performance in both the Risk and Insurance Services and Consulting segments, with underlying revenue increasing by 4% and 4% respectively on a consolidated basis for the six months. Diluted Earnings Per Share (EPS) also demonstrated positive growth, rising 8% to $2.45 for the quarter and 3% to $5.23 for the six-month period. The company continues to execute its growth strategy through targeted acquisitions, completing five in the Risk and Insurance Services segment and two in the Consulting segment during the first half of the year. Furthermore, Marsh & McLennan is actively returning capital to shareholders through share repurchases and dividends, demonstrating financial strength and a commitment to shareholder value.

Jul 17, 2025 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Financial Results (Jul 17, 2025)

Marsh McLennan reported second-quarter 2025 results with revenue of $7.0 billion, up 12% on a GAAP basis but only 4% on an underlying basis, as the McGriff acquisition contributed most of the reported growth. GAAP operating income rose 11% to $1.8 billion, and adjusted operating income rose 14% to $2.1 billion. GAAP diluted EPS was $2.45, up 8%, and adjusted EPS was $2.72, up 11%. Adjusted figures exclude noteworthy items and identified intangible amortization, and the company changed its adjusted methodology in Q1 2025, so prior-year figures have been restated for comparison. Growth was uneven across segments. Risk & Insurance Services revenue rose 15% (4% underlying), with Marsh up 18% (5% underlying) and Guy Carpenter up 7% (5% underlying). Consulting revenue rose 7% (3% underlying), with Mercer up 3% underlying and Oliver Wyman up 3% underlying. Mercer's Career business declined 5% on an underlying basis. Interest expense rose sharply to $243 million from $156 million, a 56% increase, reflecting higher debt tied to acquisition financing, which is a key headwind to bottom-line conversion. Capital returns remain a focus. The board raised the quarterly dividend 10% to $0.90 per share, and the company repurchased $300 million of stock in Q2 and $600 million year to date. Total equity increased to $15.98 billion from $13.54 billion at year-end 2024, and six-month operating cash flow improved to $1.05 billion from $434 million. The 8-K furnishes the press release under Item 2.02 and does not constitute a filing under Section 18 of the Exchange Act.

Jul 17, 2025 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Executive Changes (Jul 9, 2025)

Marsh & McLennan Companies, Inc. filed a Form 8-K on July 9, 2025 to report the appointment of Bruce Broussard, age 63, as an independent member of its Board of Directors, effective immediately. The Board also named him to the Audit Committee, determining that he meets all applicable requirements, including independence standards. The filing is a governance update and contains no financial results, guidance, or material financial impact. Broussard brings more than 30 years of healthcare leadership. He was President of Humana from 2011 and its CEO from 2013 to 2024, and earlier held CEO and CFO roles at McKesson Specialty/US Oncology. He also sits on the boards of HP Inc., Cleveland Clinic, and One Call. Management framed the appointment around insurance and healthcare expertise and executive finance experience. Following the appointment, the Board has 12 directors. His addition to the Audit Committee is the most relevant item for investors, since it strengthens oversight of financial reporting and controls. As a non-management director, Broussard will receive compensation under the company's existing independent director arrangements, which were previously disclosed as an exhibit to the Q2 2024 Form 10-Q. The filing does not specify new compensation terms or equity grants tied to this appointment.

Jul 9, 2025 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Shareholder Vote Results (May 19, 2025)

Marsh & McLennan Companies, Inc. (MRSH) filed an 8-K report on May 19, 2025, detailing the results of its Annual Meeting of Stockholders held on May 15, 2025. The meeting saw a strong turnout, with 90% of outstanding shares represented. Key outcomes include the overwhelming election of all eleven director nominees for a one-year term and the non-binding approval of executive compensation. Additionally, stockholders ratified Deloitte & Touche LLP as the independent auditor for fiscal year 2025 and approved the Amended and Restated 2020 Incentive and Stock Award Plan. These results indicate broad shareholder support for the company's leadership, compensation structure, and governance practices.

May 19, 2025 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Financial Results (Apr 17, 2025)

Marsh & McLennan (MMC, which the filing and press release identify by the ticker NYSE: MMC even though the request lists MRSH) reported first quarter 2025 results on April 17, 2025. Consolidated revenue rose 9% to $7.1 billion, but underlying revenue growth was 4%, with the gap driven mainly by the McGriff acquisition (about 7 points of Marsh-related acquisition impact, with currency a 2-point headwind). GAAP operating income grew 4% to $2.0 billion, while adjusted operating income grew 8% to $2.2 billion. GAAP diluted EPS fell 1% to $2.79, while adjusted EPS rose 5% to $3.06. Note that the company changed its non-GAAP methodology this quarter to exclude intangible amortization and other net benefit credits, and prior-year figures were restated to match. Adjusted EPS also included a $0.10 benefit from favorable discrete tax items and a $0.05 foreign exchange headwind. Segment performance was mixed. Risk & Insurance Services revenue grew 11% (4% underlying), with Marsh up 15% (5% underlying) and U.S./Canada underlying growth of 4%. Consulting revenue grew 5% (4% underlying), with Mercer up 5% and Oliver Wyman up 4%. Within Mercer, Health grew 7% underlying, Wealth grew 3%, and Career declined 1%. Adjusted operating margin for the company was 31.8%, versus 32.0% a year earlier, and GAAP operating margin was 28.4%, versus 29.7%. Capital and balance sheet items were modest. The company repurchased $300 million of stock (1.3 million shares) and repaid $500 million of senior notes that matured in March. Short-term debt rose to $1.67 billion from $519 million, and total equity increased to $14.3 billion. Operating cash flow was negative $622 million for the quarter, consistent with the seasonal pattern of bonus payments. This 8-K furnishes the press release under Item 2.02 and does not contain any new material agreements or events requiring separate disclosure.

Apr 17, 2025 10-Q

MARSH & MCLENNAN COMPANIES, INC. Quarterly Report for Q1 Ended Mar 31, 2025

Marsh & McLennan Companies, Inc. (MRSH) reported solid performance for the first quarter of 2025, with consolidated revenue increasing by 9% year-over-year to $7.1 billion. This growth was primarily driven by a 11% increase in the Risk and Insurance Services (RIS) segment and a 5% increase in the Consulting segment. Underlying revenue growth, which excludes currency impacts and acquisitions/dispositions, was 4% across both segments, indicating strong organic demand for the company's services. Despite revenue growth, diluted earnings per share saw a slight decrease to $2.79 from $2.82 in the prior year, primarily due to higher interest expenses. The company maintained its strong financial position, completing strategic acquisitions in the RIS segment and repurchasing $300 million of its stock. The company also continues to manage its capital effectively through debt repayment and dividend declarations.

Apr 17, 2025 10-K

MARSH & MCLENNAN COMPANIES, INC. Annual Report, Year Ended Dec 31, 2024

Marsh McLennan Companies, Inc. (MRSH) reported a solid performance for the fiscal year ending December 30, 2024, with consolidated revenue reaching $24.5 billion, an increase of 8% year-over-year. This growth was driven by strong performance across both its Risk and Insurance Services segment (up 9%) and Consulting segment (up 5%), with underlying revenue increases of 8% and 6%, respectively. The company's strategic acquisitions, including the significant purchase of McGriff Insurance Services for $7.75 billion, contributed to this expansion, although also increasing debt levels. Key financial highlights include a 10% increase in operating income to $5.8 billion and a 9% rise in diluted earnings per share to $8.18. Marsh McLennan also demonstrated a commitment to shareholder returns by repurchasing $900 million of its stock and increasing dividends paid. The company continues to focus on talent development, including AI skills, and navigating a complex geopolitical and macroeconomic environment. Investors should note the company's robust revenue growth, driven by core business operations and strategic acquisitions, while also monitoring the integration of McGriff and the impact of broader economic trends.

Feb 10, 2025 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Financial Results (Jan 30, 2025)

Marsh & McLennan Companies (the press release lists its ticker as NYSE: MMC) reported strong fourth-quarter and full-year 2024 results on January 30, 2025, furnished under Item 2.02 rather than filed. Q4 revenue was $6.1 billion, up 9% GAAP and 7% on an underlying basis. GAAP operating income was $1.14 billion, and adjusted operating income rose 9% to $1.30 billion. GAAP diluted EPS was $1.59 (up 5%), and adjusted EPS rose 11% to $1.87, helped by a 5-cent discrete tax benefit and offset by a 2-cent FX headwind. For full-year 2024, revenue reached $24.5 billion (up 8%, or 7% underlying), GAAP EPS was $8.18 (up 9%), and adjusted EPS was $8.80 (up 10%). Adjusted operating margin expanded 80 basis points to 26.8%, the company's 17th consecutive year of reported margin expansion. Segment performance was broadly healthy. Marsh's Q4 underlying growth was 8%, with U.S./Canada up 8% and international up 9%. Guy Carpenter's reported Q4 revenue fell 20%, but that comparison laps a 2023 legal settlement gain. Excluding that effect, its underlying growth was 7%. Mercer grew 5% underlying and Oliver Wyman grew 7% underlying in Q4. The largest structural event was the $7.75 billion cash acquisition of McGriff Insurance Services, which closed on November 15, 2024 and was funded in part by $7.25 billion of senior notes. Long-term debt rose to $19.4 billion from $11.8 billion, and goodwill and intangibles rose to $28.1 billion from $19.9 billion. Investors will want to track integration of McGriff, deleveraging, and the 2025 leverage profile. The filing also flags a methodology change beginning Q1 2025: adjusted net income and adjusted EPS will exclude intangible amortization and other net benefit credits. The company restated 2024 adjusted EPS to $8.95 under the new method (versus $8.80 as previously reported) and 2023 to $8.14 (versus $7.99). This change will lift reported adjusted EPS going forward and makes period comparisons require the restated figures. Management stated it is well positioned for 2025.

Jan 30, 2025 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Agreement Terminated (Nov 15, 2024)

On November 15, 2024, Marsh & McLennan Companies (NYSE: MMC) completed its previously announced acquisition of McGriff Insurance Services for an aggregate cash purchase price of $7.75 billion, subject to customary adjustments. The transaction was executed through Marsh & McLennan Agency LLC (MMA), the company's indirect wholly-owned subsidiary, which merged Merger Sub into McGriff's parent entity (TIH Blocker II, Inc.), leaving McGriff Parent as a wholly owned subsidiary of MMA. The company expects to assume a deferred tax asset of roughly $500 million as part of the deal, a item investors may want to track for its future tax-related benefit. The acquisition brings McGriff's more than 3,500 colleagues into Marsh McLennan Agency and expands MMC's presence in the U.S. middle market, with McGriff offering property and casualty, surety, cyber, management liability, captives, employee benefits, and personal and life and health lines. Management frames the deal as strengthening MMA's value proposition and client capabilities, though the filing itself does not disclose projected revenue, earnings contribution, or synergy estimates. Separately, the company terminated a $-denominated bridge loan commitment letter with Citigroup Global Markets dated September 29, 2024, on November 8, 2024. The filing states the bridge facility was not needed and no payments were made, which indicates the acquisition was funded without that short-term debt facility.

Nov 15, 2024 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Corporate Update (Nov 8, 2024)

Marsh & McLennan Companies, Inc. (MRSH) has filed an 8-K report detailing a significant debt issuance completed on November 7, 2024. The company successfully raised an aggregate of $7.75 billion through the sale of various senior notes with staggered maturity dates and fixed interest rates, along with a floating rate note. This offering was made under an effective shelf registration statement filed earlier in the year and involved a syndicate of prominent underwriters. This debt issuance represents a strategic move by Marsh & McLennan to bolster its capital structure. Investors should note the diversified nature of the notes issued, ranging from short-term (2027) to long-term (2055) maturities, and the specific coupon rates associated with each tranche. The proceeds from this offering are expected to be used for general corporate purposes, which could include funding future growth initiatives, acquisitions, or refinancing existing debt, providing the company with financial flexibility.

Nov 8, 2024 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Financial Results (Oct 17, 2024)

Marsh & McLennan (NYSE: MMC) reported third-quarter 2024 results on October 17, 2024, with GAAP revenue up 6% to $5.7 billion and underlying revenue up 5%. GAAP operating income rose 11% to $1.1 billion and adjusted operating income rose 12% to $1.2 billion. GAAP diluted EPS increased 3% to $1.51, while adjusted EPS rose 4% to $1.63. Management noted that the prior-year adjusted EPS base included a 10-cent discrete tax benefit, so adjusted EPS growth would have been roughly 11% excluding that item. For the nine months, GAAP diluted EPS rose 10% to $6.59 and adjusted EPS rose 10% to $6.93, with underlying revenue growth of 7%. The segment picture was mixed. Risk & Insurance Services grew underlying revenue 6% in the quarter, led by Marsh at 7% underlying growth and Guy Carpenter at 7%. Consulting grew underlying revenue 4%, with Mercer at 5% (Health up 8%, Wealth up 4%, Career up 5%) and Oliver Wyman at only 1%. Adjusted operating margin for the consolidated company was 22.4%, versus 21.3% a year earlier, an improvement of roughly 110 basis points. The company also repurchased $300 million of stock in the quarter and $900 million year to date. The most significant strategic item is the agreement, signed September 29, 2024, to acquire McGriff Insurance Services for $7.75 billion in cash, funded by a mix of cash on hand and debt. McGriff generated about $1.3 billion of trailing twelve-month revenue, and the company expects to assume a deferred tax asset of about $500 million. The deal is targeted to close by year-end, subject to regulatory clearance. Investors will want to watch the leverage impact, integration execution, and whether the acquisition meets its stated benefits, as the company itself flags these as forward-looking risks.

Oct 17, 2024 10-Q

MARSH & MCLENNAN COMPANIES, INC. Quarterly Report for Q3 Ended Sep 30, 2024

Marsh & McLennan Companies, Inc. (MRSH) reported strong financial results for the third quarter and first nine months of 2024. Revenue increased by 6% to $5.7 billion for the quarter and 7% to $18.4 billion for the nine-month period, driven by growth in both the Risk and Insurance Services (RIS) and Consulting segments. Operating income saw a significant increase of 11% to $1.1 billion for the quarter and 12% to $4.7 billion for the nine months, reflecting improved operational efficiency and revenue growth. The company highlighted strong underlying revenue growth across its key segments, with Marsh showing robust performance, particularly in the U.S./Canada and International regions. The Consulting segment also demonstrated solid growth, with Mercer and Oliver Wyman Group contributing positively. Marsh & McLennan also announced a significant pending acquisition of McGriff Insurance Services for $7.75 billion, expected to close by year-end, indicating a strategic move to expand its market presence. The company continues to return capital to shareholders through share repurchases and dividends, demonstrating financial strength and commitment to shareholder value.

Oct 17, 2024 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Material Agreement (Sep 30, 2024)

On September 29, 2024, Marsh & McLennan Agency LLC (MMA), an indirect wholly owned subsidiary of Marsh & McLennan Companies (MMC, which the filing identifies as NYSE: MMC), signed a merger agreement to acquire McGriff Insurance Services from TIH Platform Midco, L.P. and its blocker entity, TIH Blocker II, Inc. The purchase price is $7.75 billion in cash, subject to customary adjustments. The company will also assume a deferred tax asset of roughly $500 million. McGriff reported $1.3 billion of revenue for the twelve months ended June 30, 2024 and has more than 3,500 employees. The deal is targeted to close by year-end 2024, subject to regulatory clearance and other standard closing conditions. To fund the purchase, the company entered into a commitment letter with Citigroup Global Markets for a 364-day unsecured bridge term loan of up to $7.75 billion. The commitment is subject to customary conditions and is reduced by the net proceeds of any term loan, debt, equity or equity-linked issuance, or asset dispositions completed before closing. The purchase price equals about 6.0x McGriff's trailing revenue, or roughly 5.6x after netting the assumed deferred tax asset (this is our own calculation, not a figure from the filing). Investors will want to watch the eventual financing mix, the resulting leverage, and whether the deal closes on schedule. The filing is a signing announcement. It does not disclose the target's profitability, purchase accounting, or the expected earnings impact. The merger agreement and the press release are incorporated by reference, and the representations and warranties in the agreement are made for the parties' risk allocation and should not be read as statements of fact about the company.

Sep 30, 2024 10-Q

MARSH & MCLENNAN COMPANIES, INC. Quarterly Report for Q2 Ended Jun 30, 2024

Marsh & McLennan Companies, Inc. reported solid financial results for the second quarter and first half of 2024, demonstrating consistent growth across its business segments. Total revenue for the second quarter increased by 6% year-over-year to $6.2 billion, with an 8% increase for the first half to $12.7 billion. This growth was driven by strong performance in the Risk and Insurance Services (RIS) segment, which saw an 8% revenue increase in Q2 and 9% in H1, fueled by demand for risk advisory and insurance solutions. The Consulting segment also showed growth, with revenue up 2% in Q2 and 5% in H1, supported by Mercer and Oliver Wyman Group. Profitability improved significantly, with operating income rising 13% in Q2 and 12% in H1. Diluted Earnings Per Share (EPS) increased by 10% in Q2 to $2.27 and 12% in H1 to $5.08. The company continued its strategic M&A activity, completing several acquisitions in both segments to enhance its service offerings. Marsh & McLennan also actively returned capital to shareholders through share repurchases and dividend payments, underscoring a commitment to shareholder value.

Jul 18, 2024 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Financial Results (Jul 18, 2024)

Marsh & McLennan (MMC, which the filing and user label as MRSH) reported second quarter 2024 results on July 18, 2024, showing continued broad-based growth. GAAP revenue rose 6% to $6.2 billion (6% underlying), operating income rose 13% to $1.6 billion, and adjusted operating income rose 11% to $1.7 billion. Diluted GAAP EPS grew 10% to $2.27 and adjusted EPS grew 10% to $2.41, with adjusted operating margin expanding about 130 basis points to 29.0%. For the first half, GAAP EPS rose 12% to $5.08 and adjusted EPS rose 12% to $5.30. Segment performance was mixed but generally solid. Risk & Insurance Services grew underlying revenue 7% in the quarter, led by Marsh (7% underlying) and Guy Carpenter (11% underlying). Consulting grew underlying revenue 4%, with Mercer's Health business up 9% and Oliver Wyman's underlying growth slowing to 3% in the quarter, though it remained at 8% for the first half. Mercer Wealth grew only 3% underlying, a relative soft spot. Capital allocation was shareholder-friendly: the company repurchased $300 million of stock in the quarter ($600 million year to date), repaid $600 million of matured senior notes, completed the Fisher Brown Bottrell acquisition, and the board raised the quarterly dividend 15% to $0.815 per share. Investors should note that the filing is a furnished (not filed) 8-K attaching the earnings press release, and the figures are unaudited. Free cash flow in the first half was weaker than earnings, with operating cash flow of $434 million versus $665 million a year earlier, largely reflecting seasonal accrued compensation payments and receivables growth.

Jul 18, 2024 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Executive Changes (Jul 10, 2024)

Marsh & McLennan Companies (MRSH/NYSE: MMC) filed an 8-K on July 10, 2024 to report the appointment of Jan Siegmund as an independent director, effective immediately. The Board, which now consists of 12 directors, named him to the Audit Committee after determining he meets all applicable independence and qualification requirements. The filing is a board-governance event and does not disclose any financial results, guidance, or material transactions. The company framed the appointment as part of its succession planning and board refreshment efforts. Chair H. Edward Hanway and CEO John Doyle both highlighted Siegmund's background in corporate finance, strategy, and professional services as a useful addition to the Board's perspective. Siegmund brings more than 30 years of experience, including his recent role as CFO of Cognizant Technology Solutions, which he left on retirement in early 2024, and prior executive positions at ADP, where he served as CFO and Chief Strategy Officer. For investors, this is a routine governance update with limited direct financial impact. The most relevant takeaway is the strengthening of the Audit Committee's financial expertise, given Siegmund's CFO experience at a large public company. Compensation will follow the company's standard independent director arrangements, which were previously disclosed in a 10-Q exhibit, so no new compensation package was reported.

Jul 10, 2024 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Temporary Suspension of Trading Under Employee Benefit Plans (Jun 24, 2024)

Marsh & McLennan Companies (MRSH) filed a Form 8-K on June 24, 2024 under Item 5.04 to disclose a temporary trading suspension (blackout period) tied to the migration of its 401(k) Savings & Investment Plan and the Marsh & McLennan Agency 401(k) Plan from Transamerica to Alight Solutions LLC. The blackout is expected to begin July 26, 2024 at 4:00 p.m. Eastern Time and conclude during the week of August 12, 2024. During this window, participants and beneficiaries will be unable to direct or diversify plan assets, including MMC Stock. Because plan participants cannot trade, Sarbanes-Oxley Section 306(a) and SEC Regulation BTR prohibit the Company's directors and Section 16 officers from transacting in MMC Stock acquired through their service or employment for the duration of the blackout. The restriction covers direct and indirect transactions, including those by immediate household family members, and applies whether or not the individual participates in either plan. Exemptions exist for gifts, scheduled deliveries under outstanding equity awards, and non-discretionary automatic transactions such as Rule 10b5-1 plan trades. Violations can require disgorgement of profits and expose individuals to civil and criminal penalties. For investors, this is an administrative event rather than a signal about operating performance or financial condition. The filing does not disclose any change to the company's financial results, guidance, or strategy. The main points to monitor are whether the blackout dates change (the Company has committed to notify insiders of any adjustments) and whether insider trading activity during the window is consistent with the restrictions.

Jun 24, 2024 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Shareholder Vote Results (May 17, 2024)

Marsh & McLennan Companies, Inc. (MRSH) held its Annual Meeting of Stockholders on May 16, 2024, with a significant 90.67% of outstanding shares represented. The primary outcomes of the meeting were the overwhelming approval of all eleven director nominees for a one-year term, indicating strong shareholder confidence in the current board leadership. Additionally, the "say-on-pay" proposal, which is a non-binding vote on executive compensation, received substantial support from stockholders. In contrast, a stockholder proposal regarding action by written consent was not approved. The company also saw strong ratification of its independent registered public accounting firm, Deloitte & Touche LLP, for the upcoming fiscal year. These results provide a clear picture of shareholder sentiment regarding governance and executive compensation at Marsh & McLennan Companies.

May 17, 2024 10-Q

MARSH & MCLENNAN COMPANIES, INC. Quarterly Report for Q1 Ended Mar 31, 2024

Marsh & McLennan Companies (MRSH) reported a strong first quarter for 2024, with consolidated revenue increasing by 9% to $6.5 billion compared to the same period last year. This growth was driven by solid performance in both the Risk and Insurance Services (9% revenue growth) and Consulting (9% revenue growth) segments. Operating income saw a significant 12% increase to $1.9 billion, leading to a 14% rise in diluted earnings per share to $2.82. The company actively managed its capital, repurchasing $300 million in shares and declaring a quarterly dividend of $0.71 per share. Strategically, MRSH completed six acquisitions during the quarter, bolstering its capabilities in both segments, while also divesting certain businesses. The company's financial health remains robust, supported by consistent demand for its advisory and solutions, favorable global economic conditions, and prudent financial management.

Apr 18, 2024 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Financial Results (Apr 18, 2024)

Marsh McLennan (NYSE: MMC) reported first-quarter 2024 results on April 18, 2024, with broad-based growth. GAAP revenue rose 9% to $6.47 billion, and underlying revenue (excluding currency, acquisitions, and dispositions) also rose 9%. GAAP operating income grew 12% to $1.93 billion, and adjusted operating income grew 11% to $1.97 billion. Adjusted operating margin expanded about 80 basis points to 32.0%. GAAP diluted EPS rose 14% to $2.82, and adjusted EPS rose 14% to $2.89. Risk & Insurance Services revenue grew 9% to $4.27 billion, with Marsh up 8% on an underlying basis and Guy Carpenter up 8%. Consulting revenue also grew 9% to $2.21 billion. Oliver Wyman led with 13% underlying growth, Mercer grew 6%, and Mercer Health grew 10% underlying. Management said it is well positioned for another good year in 2024. Investors should note that the quarterly operating cash flow of negative $781 million is seasonal, reflecting a $1.8 billion reduction in accrued compensation. Capital activity included $300 million of share repurchases (1.5 million shares), $1 billion of new senior notes offset by $1 billion of maturing notes, and continued bolt-on M&A, including SeaTec Consulting, Querbes & Nelson, Louisiana Companies, and Vanguard's U.S. OCIO business. The results were furnished under Item 2.02 and are not considered filed for Section 18 purposes.

Apr 18, 2024 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Executive Changes (Mar 14, 2024)

Marsh & McLennan Companies, Inc. (MRSH) filed an 8-K on March 13, 2024, reporting the upcoming retirement of a long-standing board member, Bruce P. Nolop. Mr. Nolop, who has served on the Board since 2008, will retire at the company's 2024 annual meeting of stockholders. His departure is due to personal health reasons and is not related to any disagreements with the company's operations, policies, or practices, which is a positive signal to investors regarding board stability and continued alignment.

Mar 14, 2024 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Executive Changes (Feb 23, 2024)

Marsh & McLennan Companies, Inc. (MRSH) has filed an 8-K report on February 23, 2024, detailing amendments to the employment letters of its Chief Executive Officer, John Q. Doyle, and Chief Financial Officer, Mark C. McGivney. These amendments, effective April 1, 2024, significantly adjust the compensation packages for both executives, including base salary, annual bonus targets, and long-term incentive awards. For investors, these changes signal a potential increase in executive compensation costs, though they may also reflect a strategic decision to retain and incentivize key leadership. The increased compensation is tied to performance, with bonus and LTI targets established. Investors should monitor the company's financial performance to assess the alignment between executive pay and shareholder value creation going forward.

Feb 23, 2024 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Material Agreement (Feb 20, 2024)

Marsh & McLennan Companies, Inc. (NYSE: MMC, referred to as MRSH in the request) priced and issued $1.0 billion of senior unsecured notes on February 14, 2024, with closing on February 20, 2024. The offering consists of two equal $500 million tranches: 5.150% Senior Notes due 2034 and 5.450% Senior Notes due 2054. The notes were sold off the Company's effective Form S-3 shelf registration (filed July 27, 2021) and issued under the 2011 base indenture with The Bank of New York Mellon as trustee, as supplemented by the Eighteenth Supplemental Indenture. The Company states that it intends to use the net proceeds for general corporate purposes, which the filing does not elaborate on. Investors should note that the filing does not disclose specific uses such as debt refinancing, acquisitions, or share repurchases. The filing also contains no information on pro forma leverage, interest coverage, or the Company's current credit ratings, so the credit impact must be assessed from other sources such as the 10-K and 10-Q filings. From a fixed income perspective, the 10-year tranche yields 5.150% and the 30-year tranche yields 5.450%, both pricing at par for the initial offering. The issuance is a routine, well-syndicated debt raise by a large investment-grade professional services firm, with six underwriters acting as representatives. The filing is largely administrative, consisting of the underwriting agreement, indenture supplement, and legal opinion, and it does not indicate any change in the Company's operating outlook or strategy.

Feb 20, 2024 10-K

MARSH & MCLENNAN COMPANIES, INC. Annual Report, Year Ended Dec 31, 2023

Marsh & McLennan Companies, Inc. (MRSH) reported strong financial performance in its 2023 10-K filing, with consolidated revenue reaching $22.7 billion, an increase of 10% year-over-year. This growth was driven by robust performance in both its Risk and Insurance Services segment (up 11%) and its Consulting segment (up 7%), with underlying revenue increases across both. The company highlighted significant operating income growth of 23% to $5.3 billion and a 25% increase in diluted earnings per share to $7.53, reflecting continued demand for its advisory and risk management solutions, improved market pricing, and higher interest rates boosting fiduciary income. Strategic initiatives, including 14 acquisitions throughout 2023 across its segments, demonstrate the company's commitment to growth and market expansion. Marsh McLennan also actively managed its capital structure, issuing new senior notes and repurchasing approximately $1.15 billion of its own stock. The company continues to navigate a complex macroeconomic and geopolitical landscape, with management focused on talent development and technological enhancements to maintain its competitive edge. Overall, the filing indicates a healthy and growing business with a clear strategy for expansion and shareholder value creation.

Feb 12, 2024 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Executive Changes (Feb 9, 2024)

Marsh & McLennan Companies, Inc. (MRSH) filed an 8-K on February 8, 2024, to report a key change within its Board of Directors. Raymond G. Young, a current board member, has informed the company of his decision not to seek re-election at the upcoming 2024 annual meeting of stockholders scheduled for May 16, 2024. This departure is stated to be voluntary and not a result of any disputes or disagreements with the company regarding its operations, policies, or practices. The company expressed gratitude for Mr. Young's service and contributions during his time on the board. While this represents a change in board composition, the company has indicated that Mr. Young's decision is amicable. Investors should note this transition as part of the regular governance and board refreshment processes, and it does not appear to signal any underlying operational or strategic concerns at this time.

Feb 9, 2024 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Financial Results (Jan 25, 2024)

Marsh & McLennan (MMC, which the filing and press release refer to as Marsh McLennan) reported fourth-quarter and full-year 2023 results on January 25, 2024. Full-year 2023 revenue reached $22.7 billion, up 10% on a GAAP basis and 9% on an underlying basis. GAAP operating income rose 23% to $5.3 billion and adjusted operating income rose 17% to $5.6 billion, with adjusted operating margin expanding to 26.0%, which management described as the 16th consecutive year of reported margin expansion. GAAP diluted EPS was $7.53 (up 25%), and adjusted EPS grew 17% to $7.99. Fourth-quarter results were strong: revenue of $5.6 billion grew 11% (7% underlying), and GAAP diluted EPS of $1.52 rose 63%, while adjusted EPS increased 14% to $1.68. Risk & Insurance Services led growth, with Guy Carpenter's Q4 revenue up 48% reported (9% underlying) and Consulting adjusted operating income up 18% in the quarter. Mercer's Health and Wealth lines were key drivers, while Marsh's underlying growth was 6% in Q4 and 8% for the full year. Capital allocation included $1.15 billion of share repurchases in 2023 (6.4 million shares), $1.3 billion in dividends, $976 million in acquisitions (including Honan in Australia/New Zealand), and repayment of $250 million of senior notes. Total debt rose meaningfully, with short-term debt at $1.6 billion and long-term debt at $11.8 billion at year-end. Note that this 8-K furnishes the earnings release under Item 2.02 and is not a comprehensive filing, so forward guidance and detailed risk disclosures are not included here.

Jan 25, 2024 10-Q

MARSH & MCLENNAN COMPANIES, INC. Quarterly Report for Q3 Ended Sep 30, 2023

Marsh & McLennan Companies, Inc. (MRSH) reported strong financial results for the third quarter and first nine months of 2023, showcasing robust revenue growth and increased profitability across its Risk and Insurance Services and Consulting segments. The company saw a significant increase in revenue, up 13% year-over-year for the quarter and 9% for the year-to-date period, driven by strong underlying demand, client retention, and favorable insurance/reinsurance rates. Operating income and net income also saw substantial growth, reflecting effective cost management alongside revenue expansion. Key drivers for the improved performance include elevated interest income on fiduciary funds due to higher interest rates, successful acquisitions bolstering segment revenues, and continued client demand for advisory and risk management services. The company also highlighted its ongoing share repurchase program and consistent dividend payments, signaling a commitment to returning value to shareholders. Despite ongoing macroeconomic uncertainties and geopolitical risks, Marsh & McLennan demonstrates resilience and strategic execution, positioning itself for continued growth.

Oct 19, 2023 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Financial Results (Oct 19, 2023)

Marsh McLennan (NYSE: MMC) reported strong third-quarter 2023 results, with GAAP revenue up 13% to $5.4 billion and underlying revenue up 10%. GAAP operating income rose 26% to $996 million and adjusted operating income rose 24% to $1.1 billion. GAAP diluted EPS increased 36% to $1.47, and adjusted EPS increased 33% to $1.57. Management described the quarter as outstanding and said the company is on track for another strong year while continuing to invest for the future. Note that the adjusted EPS figure included a 10-cent benefit from favorable discrete tax items, which flatters the quarterly comparison. For the first nine months of 2023, revenue reached $17.2 billion (up 9%, or 10% underlying), GAAP diluted EPS rose 18% to $6.01, and adjusted EPS rose 17% to $6.31. Growth was broad-based: Risk & Insurance Services revenue grew 12% for the nine months, with Marsh and Guy Carpenter both showing solid underlying gains, while Oliver Wyman grew 8% underlying and Mercer 7% underlying. Operating margin expansion was evident, with adjusted operating margin at 26.9% for the nine months versus 25.6% a year earlier. From a capital perspective, the company repurchased $900 million of stock year-to-date and issued $1.6 billion of senior notes in the third quarter. Total debt rose meaningfully, with short-term debt increasing to $1.9 billion from $268 million at year-end 2022, and cash and cash equivalents of $2.9 billion were held against this. The filing is a furnished (not filed) Item 2.02 report, and the results are presented largely on a GAAP basis with non-GAAP adjustments reconciled in the attached exhibit.

Oct 19, 2023 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Executive Changes (Oct 12, 2023)

Marsh & McLennan (MRSH/NYSE: MMC) disclosed on October 12, 2023 a leadership transition within Mercer, its global human capital and consulting business. Mercer President and CEO Martine Ferland informed the company on October 9, 2023 of her intention to retire on March 31, 2024. Patrick (Pat) Tomlinson was simultaneously named President of Mercer effective immediately, and will succeed Ferland as Mercer President and CEO and Vice Chair of Marsh McLennan effective April 1, 2024. This is a planned, orderly succession rather than a disruption, and Ferland remains in her role through the transition period. The filing's operational details matter for investors. Tomlinson will initially report to Ferland and oversee Mercer's global Health, Wealth and Career practices, while retaining his existing roles as Marsh McLennan US and Canada CEO and Mercer US and Canada President in the near term. Upon taking the top Mercer role, he will also join Marsh McLennan's Executive Committee, reporting to John Doyle, Marsh McLennan President and CEO. Doyle publicly endorsed the appointment, citing Tomlinson's record of delivering growth and driving transformation. For investors, the 8-K signals continuity and internal succession with no reported financial impact, guidance change, or restatement. Mercer is a major contributor to Marsh McLennan's revenue base, so the focus is on execution risk during the handover, especially given Tomlinson's concurrent responsibilities in the US and Canada. The filing does not disclose compensation terms for the new role, so any related compensation changes would need to be evaluated in a future proxy statement or 8-K.

Oct 12, 2023 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Material Agreement (Sep 11, 2023)

On September 6, 2023, Marsh & McLennan Companies (NYSE: MMC, ticker cited as MRSH in the filing header) priced a $1.6 billion senior notes offering, consisting of $600 million of 5.400% Senior Notes due 2033 and $1.0 billion of 5.700% Senior Notes due 2053. The underwriting agreement was with BofA Securities, Citigroup Global Markets, J.P. Morgan and Deutsche Bank as representatives of the underwriters. The notes were issued on September 11, 2023 under a 2011 base indenture with The Bank of New York Mellon, as supplemented by a Seventeenth Supplemental Indenture, and were registered under an effective Form S-3 shelf filed in July 2021. The company stated that net proceeds will be used for general corporate purposes. The filing does not specify a particular use such as debt refinancing, acquisitions, or share repurchases, so investors should note that the offering adds roughly $1.6 billion of long-dated fixed-rate debt without a stated deleveraging or growth-investment objective. The coupons of 5.4% and 5.7% reflect the prevailing rate environment at pricing and lock in borrowing costs for up to 30 years. For investors, the event is primarily a capital-structure and liquidity action rather than an operational one. It does not change revenue, earnings, or guidance, and the filing contains no financial results. The main considerations are the incremental interest expense (roughly $90 million annually at the stated coupons, before any offsetting uses of proceeds) and the company's long-term funding profile. Investors should review the prospectus supplement and the company's subsequent filings for the intended use of proceeds and any effect on leverage metrics.

Sep 11, 2023 10-Q

MARSH & MCLENNAN COMPANIES, INC. Quarterly Report for Q2 Ended Jun 30, 2023

Marsh & McLennan Companies, Inc. (MRSH) reported strong financial performance for the second quarter and first half of 2023. Revenue increased by 9% to $5.9 billion for the quarter and 8% to $11.8 billion for the half-year, driven by robust growth in the Risk and Insurance Services segment, which saw revenue climb 12% and 11% respectively, and solid performance in Consulting. Net income attributable to the company rose to $1.035 billion ($2.07 per diluted share) for the quarter and $2.270 billion ($4.55 per diluted share) for the half-year, marking an 8% and 13% increase respectively compared to the prior year. The company also continued its share repurchase program and declared a quarterly dividend, demonstrating a commitment to returning value to shareholders while investing in strategic acquisitions, such as the Westpac transaction in the Consulting segment.

Jul 20, 2023 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Financial Results (Jul 20, 2023)

Marsh & McLennan reported second quarter 2023 results that beat its prior-year pace on most measures. GAAP revenue rose 9% to $5.9 billion, and underlying revenue (excluding currency and acquisition/disposition effects) grew 11%. GAAP operating income increased 7% to $1.46 billion, while adjusted operating income rose 17% to $1.54 billion. Diluted GAAP EPS grew 8% to $2.07, and adjusted EPS grew 16% to $2.20. For the first half of 2023, GAAP EPS rose 13% to $4.55 and adjusted EPS rose 13% to $4.74. Risk & Insurance Services was the main driver, with revenue up 12% (13% underlying) and adjusted operating margin of 34.2%. Consulting revenue grew 4% (8% underlying), though reported operating income fell 18% because the prior-year quarter included a $112 million gain on the sale of the Mercer U.S. affinity business. Capital return remained active. The company repurchased $300 million of stock in the quarter and $600 million year to date, and the board raised the quarterly dividend 20% to $0.710 per share. Balance sheet changes warrant attention: short-term debt rose to $2.375 billion from $268 million at year-end 2022, and total equity increased to $12.1 billion. The company also changed how it presents fiduciary cash and liabilities, which moved both to current assets and current liabilities and inflated reported total assets. This is a presentation change, not an operational one. The filing is a furnished (not filed) Item 2.02 8-K attaching the earnings press release. The release identifies the company's ticker as NYSE: MMC, which is the ticker used for Marsh McLennan in the source material. The company is the parent of Marsh, Guy Carpenter, Mercer, and Oliver Wyman.

Jul 20, 2023 8-K

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Executive Changes (Jun 12, 2023)

Marsh & McLennan Companies, Inc. filed this Form 8-K on June 12, 2023 to report that Hafize Gaye Erkan resigned from its Board of Directors, effective immediately. Ms. Erkan had served on the Board since early 2022 and sat on the Audit and Directors and Governance committees. The company states that her departure follows her recent appointment as Governor of Türkiye's Central Bank and is not the result of any disagreement with the company on its operations, policies, or practices. The filing is administrative rather than financial. It contains no financial results, guidance, transaction, or charge, and it does not disclose a replacement director or changes to committee composition. The press release (Exhibit 99.1) quotes Independent Chairman Edward Hanway thanking Ms. Erkan for her insights and operational experience and wishing her well in her new role. For investors, the event is low in materiality. The main points to monitor are whether the Board fills the vacancy and how it reassigns her Audit and Directors and Governance committee seats, since those committees are central to governance and financial oversight. The resignation's stated cause is a government appointment, which the company says is unrelated to any dispute. The filing references NYSE: MMC as the company's ticker.

Jun 12, 2023